Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Response and relapse rates after treatment with long‐acting somatostatin analogs in multifocal or recurrent type‐1 gastric carcinoids: A systematic review and meta‐analysis

Published:2020-03 Issue:2 Volume:8 Page:140-147
ISSN:2050-6406
Container-title:United European Gastroenterology Journal
language:en
Short-container-title:United European Gastroenterol. j.

Author:

Rossi Roberta Elisa¹,Invernizzi Pietro²,Mazzaferro Vincenzo¹,Massironi Sara³

Affiliation:

1. Gastrointestinal and Hepato‐Pancreatic Surgery and Liver Transplantation UnitFondazioneRCCS Istituto Nazionale Tumori (INT, National Cancer Institute) and Università degli Studi di MilanoMilanItaly

2. Department of Gastroenterology and Center for Liver Autoimmune DiseasesSan Gerardo HospitalMonzaItaly

3. Gastroenterology and Endoscopy UnitFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoMilanItaly

Publisher

Wiley

Subject

Gastroenterology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2050640619890465

Reference51 articles.

1. A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?

2. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters

3. ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms